Blackhawk Growth Corp
List of articles in category 2022 News
Title Created Date
Dec 19 Blackhawk Growth's Spaced Food To Launch In Canada's Largest Market
Dec 02 Blackhawk Growth Receives Court Approval to Hold Special Meeting on December 22nd 2022 to Approve Mindbio Therapeutics Spinout
Nov 07 Blackhawk Growth Announces Shareholder Meeting for December 22, 2022 to Vote on the Spin-Out of Mindbio Therapeutics
Nov 04 Blackhawk's Mindbio Reveals Positive Data From Phase 1 Randomised Double-Blind Placebo Controlled Clinical Trials Microdosing LSD In 80 Healthy Participants
Oct 28 Blackhawk Growth to Reprofile Existing Credit Facility and Add Additional $2 Million Dollar Facility
Sep 28 BLACKHAWK's Mindbio Announces Phase 2A/B Clinical Trials Microdosing LSD in Major Depressive Disorder Submitted for Ethics & Regulatory Approval
Sep 22 BLACKHAWK's Mindbio Nominated for Company of the Year by Industry Peers as it Prepares for Phase 2 Clinical Trials
Sep 15 Blackhawk's MindBio Therapeutics Announces Reveal Date for Presentation of Phase 1 Clinical Trial Data
Aug 29 Blackhawk Growth's Spaced Food Manufacturing Partner Completes Development of Spaced Food Edibles; Prepares for Commercial Production
Aug 09 Blackhawk Growth Sets AGM Date and Provides Corporate Update
Jul 25 Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder
Jun 16 Blackhawk's Terp Wholesale LLC Reports Unaudited Cdn$1,644,043 in Gross Revenue for First Five Months Ended May 31st, 2022
Jun 06 Blackhawk Appoints Justin Hanka as Chairman of The Board
May 30 Blackhawk Growth Files Quarter Ended March 31, 2022 Financials and Reports Increase in Value of its Portfolio by 8.8% Quarter Over Quarter
May 24 Blackhawk's Terp Wholesale LLC Expands Facility, Launches Retail Delivery
May 11 Blackhawk's Mindbio Therapeutics Accelerates Global Communications Expansion Ahead of Phase 2 Clinical Trials
May 03 Blackhawk's MindBio Therapeutics Announces Completion of World First Phase 1 Microdosing Clinical Trial
Apr 28 Blackhawk Growth Closes Investment in Blum Distributors
Apr 19 BLACKHAWK GROWTHS Blum Distributors Expands Facility and Starts to Fulfill Applied Myco Order
Apr 06 BLACKHAWK GROWTH to Acquire Mycology Supplier and Cultivator - Blum Distributors
Apr 04 Blackhawk's MindBio Therapeutics Enters its 80th and Final Patient into Phase 1 Clinical Trials and Provides Update for MindBio Spinout
Mar 31 Blackhawk Growth's Spaced Food Adds New Flavours and Signs Partnership Agreement with Gaia Grow's Canadian Cannabis Laboratory Tru Extracts for Manufacturing of Blackhawk's Spaced Food Products
Mar 15 Blackhawks Mindbio Therapeutics Announces Investment in Health Research Platform Quantified Citizen, a Health Technology Company Disrupting and Decentralizing Clinical Research
Mar 11 Blackhawk Growth Closes Investment in Stable Foods
Mar 10 Blackhawk's MindBio Therapeutics Invests NZ$2.3 Million to Fast Track Psychedelic Microdosing Phase 2 Clinical Trials
Mar 08 Blackhawk's MindBio Therapeutics Announces Platinum Sponsorship of Plant Medicine Week in Malta
Feb 28 Blackhawk Growth to Acquire Remaining 49% of NuWave Foods; NuWave Foods Changes Name to Stable Foods
Feb 17 Blackhawk Subsidiary Digital Mind Technology Starts Phase 1 Development of Digital Therapeutic Platform and is on Track for Completion in Q2, 2022
Feb 03 Blackhawk Publishes MindBio Therapeutics Investor Presentation & Q&A Event on Website
Feb 01 Blackhawk CEO Frederick Pels and MindBio Therapeutics Co-Founder Justin Hanka Will Lead Investor Presentation and Q&A Session Wednesday, February 2nd at 3pm Pacific Standard Time
Jan 26 Blackhawk Launches New Website, Corporate Presentation and Engages Investor Relations Professional to Expand Outreach
Jan 24 Blackhawk's MindBio Therapeutics Ahead of Schedule to Complete Phase 1 Clinical Trial Microdosing of Psychedelic Medicines and Provides Updates on Spinout Process
Jan 17 Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder
Jan 12 Blackhawk’s TERP Wholesale LLC Receives State-Issued Micro-Business License Allowing for Retail Delivery
Jan 06 Blackhawk’s TERP Wholesale LLC Reports Unaudited $2,503,133 in Gross Revenue for Nine Months Ended September 30th, 2021
Jan 04 Blackhawk’s MindBio Therapeutics to Develop Proprietary Drug Delivery Technology for Psychedelic Medicines